The pharma/biotech sector has picked up this year after being battered by the drug pricing controversy in 2016. The first half has been pretty strong for companies in the space. The NYSE ARCA Pharmace...
“I think it all comes down to motivation. If you really want to do something, you will work hard for it.” – Edmund Hillary Some better action today in the bio, pharma and tech sector but action ...
Wheat supplies were slightly higher, but Weather now rules Market Analysis This month’s US supply/demand revisions generally followed the indications from June 30th quarterly stocks changes. Old-c...
Lethargic summer markets tend to instill a sense of false security. Stocks and property are near all-time highs, interest rates are at 72-year lows and most investors feel richer than ever. Central ba...
So yeah, another day, another largely fruitless effort to figure out what exactly the message is from DM central bankers. Yellen was, well, Yellen, and her second day on Capitol Hill brought little in...
Vol-sellers beware. That’s the message from Natixis Global Asset Management’s Brett Olsen and Nicholas J. Elward, in their latest note, as they warn “it stands to reason that the mark...
Shares of corrugated box maker International Paper (IP) are outperforming broader market measures after being upgraded to buy on eCommerce drivers. E-COMMERCE GROWTH: Goldman Sachs’ analyst Bria...
There’s no denying that every iPhone release has an impact on AAPL stock, and there are certain patterns the shares follow around the announcement and availability dates. With this year marking the ...
The CBO has just released an assessment of the President’s budget proposal. Balancing the budget looks unrealistic, even given massively sweeping (and unrealistic) spending cuts. Here are the proj...